The safety and efficacy of fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) combination in the front-line treatment for patients with advanced gastric or gastroesophageal adenocarcinoma: phase II trial.
about
Positioning of second-line treatment for advanced gastric and gastroesophageal junction adenocarcinomaLeptomeningeal Carcinomatosis in Gastric Cancer: A Therapeutical ChallengeDocetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma.Routine Radiologic Contrast Agent Examination After Gastrectomy for Gastric Cancer Is Not Useful.
P2860
The safety and efficacy of fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) combination in the front-line treatment for patients with advanced gastric or gastroesophageal adenocarcinoma: phase II trial.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The safety and efficacy of flu ...... denocarcinoma: phase II trial.
@ast
The safety and efficacy of flu ...... denocarcinoma: phase II trial.
@en
type
label
The safety and efficacy of flu ...... denocarcinoma: phase II trial.
@ast
The safety and efficacy of flu ...... denocarcinoma: phase II trial.
@en
prefLabel
The safety and efficacy of flu ...... denocarcinoma: phase II trial.
@ast
The safety and efficacy of flu ...... denocarcinoma: phase II trial.
@en
P2860
P1433
P1476
The safety and efficacy of flu ...... denocarcinoma: phase II trial.
@en
P2093
Abeer Hussien Anter
Rasha Mohamed Abdel-Latif
P2860
P2888
P356
10.1007/S12032-012-0451-1
P577
2013-01-10T00:00:00Z
P6179
1033317438